Due to the increasing global importance of decarbonizing human activities, especially the production of electricity, the optimal deployment of renewable energy technologies will play a crucial role in future energy systems. To accomplish this, particular attention must be accorded to the geospatial and temporal distribution of variable renewable energy sources (VRES) such as wind and solar radiation in order to match electricity supply and demand. This study presents a techno-economical assessment of four energy technologies in the hypothetical context of Mexico in 2050, namely: onshore and offshore wind turbines, and open-field and rooftop photovoltaics. A land eligibility analysis incorporating physical, environmental, and socio-political eligibility constraints and individual turbine and photovoltaic park simulations, drawing on 39 years of climate data, is performed for individual sites across the country in an effort to determine the installable potential and the associated levelized costs of electricity. The results reveal that up to 54 PWh of renewable electricity can be produced as a cost of less than 70 EUR/MWh. Around 91% (49 PWh) of this would originate from 23 TW of open-field photovoltaic parks that could occupy up to 578,000 km2 of eligible land across the country. The remaining 9% (4.8 PWh) could be produced by 1.9 TW of onshore wind installations allocated to approximately 68,500 km2 of eligible land that is almost fully adjacent to three mountainous zones. The combination of rooftop photovoltaic and offshore wind turbines account for a very small share of less than 0.03% of the overall techno-economical potential.

Clinical trials for Alzheimer’s disease (AD) face multiple challenges, such as the high screen failure rate and even allocation of heterogeneous participants. Artificial intelligence (AI), which has become a potent tool of modern science with the expansion in the volume, variety, and velocity of biological data, offers promising potential to address these issues in AD clinical trials. In this review, we introduce the current status of AD clinical trials and topic of machine learning. Then, a comprehensive review is focused on the potential applications of AI in the steps of AD clinical trials, including the prediction of AD biomarkers and differential diagnosis of AD in the prescreen during eligibility assessment and the likelihood stratification of patients who will progress to AD dementia and fast cognitive decline group from the slow decline group in randomization. Finally, this review provides challenges, developments and the future outlook on the integration of AI into AD clinical trials.

Considering the need to reduce greenhouse gas emissions, onshore wind energy is certain to play a major role in future energy systems. This topic has received significant attention from the research community, producing many estimations of Europe's onshore wind potential for capacity and generation. Despite this focus, previous estimates have relied on distribution assumptions and simulation schemes that summarily under predict both the amount of available future wind capacity as well as its performance. Foremost in this regard is the common use of contemporary, or at least near-future, turbine designs which are not fitting for a far-future context. To fulfill this role, an improved, transparent, and fully reproducible work flow is presented for determining European onshore wind potential. Within a scenario of turbine cost and design in 2050, 13.5 TWof capacity is found to be available, allowing for 34.4 PWh of generation. By sorting the explicitly-placed potential generation locations by their expected generation cost, national relations between turbine cost and performance versus a desired capacity are exposed. In this way, it is shown that all countries possess some potential for onshore wind energy generation below 4 €_ct kWh^-1. and, furthermore, that it is unlikely for these costs to exceed 6 €_ct kWh^-1.